Markets:

Overview

News

Currencies

International

Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

13.70 -0.45 (-3.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024

March 14, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System

March 08, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study

February 14, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium

January 31, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp

January 02, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter

December 20, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday? ↗

December 19, 2023

Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...

Via Benzinga

$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗

December 13, 2023

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Insiders Buying Dave And 2 Other Stocks ↗

December 07, 2023

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Insiders Buying Westrock Coffee And 3 Other Stocks ↗

December 04, 2023

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock....

Via Benzinga

Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday ↗

November 21, 2023

U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday.

Via Benzinga

Topics Stocks

Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode

November 21, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

November 15, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results

November 13, 2023

From Pulse Biosciences, Inc.

Via Business Wire

UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call

November 10, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023

October 30, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery

October 24, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study

October 02, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit

September 29, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting

September 27, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase

September 07, 2023

From Pulse Biosciences, Inc.

Via Business Wire

The Truth About IPO Investing ↗

September 02, 2023

When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are...

Via Talk Markets

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 29, 2023

Via Benzinga

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 29, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.

Via Benzinga

Topics Intellectual Property

Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 28, 2023

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

Via Benzinga

Pulse Biosciences Clarifies Details of Recent S-3 Filing

August 24, 2023

From Pulse Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.